NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
The family of voltage-dependent anion channels (VDAC) comprises three isoforms (VDAC-1, VDAC-2, VDAC-3). VDAC has been extensively described as localized in the outer mitochondrial membrane where it is involved in the exchange of ions, metabolites and ATP/ADP between mitochondria and cytosol. VDAC interacts with disease specific proteins and thus regulates the mitochondrial function and controls the cellular energy resources explaining its involvement in cell death and apoptosis. In addition, VDAC-1 and -2 can also be found at other cellular locations such as in the sarcoplasmic reticulum, in the endoplasmic reticulum as well as in the plasma membrane. Through single channel pore regulation, oligomerization or changed expression levels VDAC is involved in different neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic lateral sclerosis, Huntington’s disease and others. Here, we critically summarize current discussions about VDAC as a common key player for these diseases. We suggest that VDAC acts as a transmembrane multifunctional regulatory protein which might serve as a pharmacological target for the development of novel drugs against neurodegenerative diseases such application of recombinant antibody technology.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.